Special Drug Use-results Survey for long-term use of Doxil injection 20mg (ovarian cancer aggravated after chemotherapy)
Not Applicable
- Conditions
- ovarian cancer aggravated after chemotherapy
- Registration Number
- JPRN-UMIN000015902
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety(Adverse Drug Reaction) Effectiveness(Antitumor efficacy)
- Secondary Outcome Measures
Name Time Method